Cas:503536-77-4 5-[4-(dimethylamino)phenyl]pyridin-2-amine manufacturer & supplier

Chemical Name:5-[4-(dimethylamino)phenyl]pyridin-2-amine

CAS.NO:503536-77-4

Synonyms:qc-4945

Molecular Formula:C₁₃H₁₅N₃

Molecular Weight:213.27800

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:383.132ºC at 760 mmHg

Density:1.133

Index of Refraction:1.636

PSA:42.15000

Exact Mass:213.12700

LogP:2.97800

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like qc-4945 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,qc-4945 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,qc-4945 Use and application,qc-4945 technical grade,usp/ep/jp grade.

Related News: On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business. 5-[4-(dimethylamino)phenyl]pyridin-2-amine manufacturer The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers. 5-[4-(dimethylamino)phenyl]pyridin-2-amine supplier The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. 5-[4-(dimethylamino)phenyl]pyridin-2-amine vendor But they’ll be subject to up to 14 days of mandatory quarantine once they’re back in the US. 5-[4-(dimethylamino)phenyl]pyridin-2-amine factory From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.